ID | 65709 |
フルテキストURL | |
著者 |
Iwamuro, Masaya
Department of Gastroenterology and Hepatology, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
Kagawa, Shunsuke
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
Inoo, Shoko
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Otsuka, Motoyuki
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
|
抄録 | Herein, we present a case of collagenous colitis in a patient who underwent chemotherapy for gastric cancer, comprising five cycles of S-1 plus oxaliplatin and trastuzumab, followed by five cycles of paclitaxel and ramucirumab and seven cycles of nivolumab. The subsequent initiation of trastuzumab deruxtecan chemotherapy led to the development of grade 3 diarrhea after the second cycle of treatment. Collagenous colitis was diagnosed via colonoscopy and biopsy. The patient's diarrhea improved following the cessation of lansoprazole. This case highlights the importance of considering collagenous colitis as a differential diagnosis, in addition to chemotherapy-induced colitis and immune-related adverse event (irAE) colitis, in patients with similar clinical presentations.
|
キーワード | immune checkpoint inhibitor
chemotherapy-induced diarrhea
immune-related adverse event colitis
colonoscopy
collagenous colitis
|
発行日 | 2023-05-25
|
出版物タイトル |
Cureus
|
巻 | 15巻
|
号 | 5号
|
出版者 | Springer
|
開始ページ | e39466
|
ISSN | 2168-8184
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2023 Iwamuro et al.
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.7759/cureus.39466
|
ライセンス | https://creativecommons.org/licenses/by/4.0/
|
Citation | Iwamuro M, Tanaka T, Kagawa S, et al. (May 25, 2023) Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy. Cureus 15(5): e39466. doi:10.7759/cureus.39466
|